Murayama E - Search Results

1

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-Week Study of Mirogabalin in Chinese Patients with Diabetic Peripheral Neuropathic Pain.

Guo X, Yu Y, Zhang Y, Sun L, Li Y, Song B, Hang L, Baba M, Wasaki Y, Kikumori K, Murayama E. Guo X, et al. Among authors: murayama e. Pain Ther. 2024 Aug;13(4):937-952. doi: 10.1007/s40122-024-00617-2. Epub 2024 Jun 19. Pain Ther. 2024. PMID: 38896199 Free PMC article.

2

Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study.

Baba M, Kuroha M, Ohwada S, Murayama E, Matsui N. Baba M, et al. Among authors: murayama e. Pain Ther. 2020 Jun;9(1):261-278. doi: 10.1007/s40122-020-00156-6. Epub 2020 Feb 12. Pain Ther. 2020. PMID: 32052264 Free PMC article.

3

Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies.

Kato J, Baba M, Kuroha M, Kakehi Y, Murayama E, Wasaki Y, Ohwada S. Kato J, et al. Among authors: murayama e. Clin Ther. 2021 May;43(5):822-835.e16. doi: 10.1016/j.clinthera.2021.03.015. Epub 2021 May 29. Clin Ther. 2021. PMID: 34059327 Free article. Clinical Trial.

4

Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients.

Kato J, Matsui N, Kakehi Y, Murayama E, Ohwada S, Sugihara M. Kato J, et al. Among authors: murayama e. Pain. 2019 May;160(5):1175-1185. doi: 10.1097/j.pain.0000000000001501. Pain. 2019. PMID: 30913164 Free PMC article. Clinical Trial.

5

Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia: Results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial.

Kato J, Matsui N, Kakehi Y, Murayama E, Ohwada S. Kato J, et al. Among authors: murayama e. Medicine (Baltimore). 2020 Sep 4;99(36):e21976. doi: 10.1097/MD.0000000000021976. Medicine (Baltimore). 2020. PMID: 32899037 Free PMC article. Clinical Trial.

6

Alcam-a and Pdgfr-α are essential for the development of sclerotome-derived stromal cells that support hematopoiesis.

Murayama E, Vivier C, Schmidt A, Herbomel P. Murayama E, et al. Nat Commun. 2023 Mar 1;14(1):1171. doi: 10.1038/s41467-023-36612-y. Nat Commun. 2023. PMID: 36859431 Free PMC article.

7

Hippocampus as a sorter and reverberatory integrator of sensory inputs.

Nomoto M, Murayama E, Ohno S, Okubo-Suzuki R, Muramatsu SI, Inokuchi K. Nomoto M, et al. Among authors: murayama e. Nat Commun. 2022 Dec 20;13(1):7413. doi: 10.1038/s41467-022-35119-2. Nat Commun. 2022. PMID: 36539403 Free PMC article.

8

A short-term memory trace persists for days in the mouse hippocampus.

Wally ME, Nomoto M, Abdou K, Murayama E, Inokuchi K. Wally ME, et al. Among authors: murayama e. Commun Biol. 2022 Nov 3;5(1):1168. doi: 10.1038/s42003-022-04167-1. Commun Biol. 2022. PMID: 36329137 Free PMC article.

9

A dual involvement of Protocadherin 18a in stromal cell development guides the formation of a functional hematopoietic niche.

Touret AL, Vivier C, Schmidt A, Herbomel P, Murayama E. Touret AL, et al. Among authors: murayama e. Development. 2022 Oct 1;149(19):dev200278. doi: 10.1242/dev.200278. Epub 2022 Oct 3. Development. 2022. PMID: 36168784

10

A cortical cell ensemble in the posterior parietal cortex controls past experience-dependent memory updating.

Suzuki A, Kosugi S, Murayama E, Sasakawa E, Ohkawa N, Konno A, Hirai H, Inokuchi K. Suzuki A, et al. Among authors: murayama e. Nat Commun. 2022 Jan 11;13(1):41. doi: 10.1038/s41467-021-27763-x. Nat Commun. 2022. PMID: 35017495 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters